<DOC>
	<DOCNO>NCT01113515</DOCNO>
	<brief_summary>The purpose study determine safety efficacy new gel formulation Esmolol hydrochloride ( Galnobax® ) treatment Diabetic Foot Ulcer ( DFU ) . The study compare number type adverse event occur , rate wind closure percentage wound close Galnobax treat group versus placebo group .</brief_summary>
	<brief_title>Clinical Investigation Galnobax® Treatment Diabetic Foot Ulcers</brief_title>
	<detailed_description>This interventional , placebo-controlled , randomize , double-blinded , dose comparison , phase I/II study Galnobax® subject diabetic foot ulcer . Additionally effect dosage frequency application also study . The total trial duration per subject 25 week comprise 1 week screening , 12 week treatment 12 week follow-up .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Esmolol</mesh_term>
	<criteria>Subjects age 18 95 year , inclusive , Type 1 Type 2 diabetes undergoing therapy glycemic control Subjects knee ulcer least 4 week maximum 52 week duration full thickness ulcer without exposure bone , muscle , ligament , tendon Ulcer clinically noninfected Ulcer area ( length x width ) measurement 1.5 cm2 10 cm2 , inclusive post debridement ulcer area less equal 12 cm2 . Fullthickness ulcer Grade 1 Grade 2 per Wagner 's classification system Recently debrided ulcer ( 2 week prior screen ) post debridement ulcer free necrotic debris , foreign body , sinus tract , tunnel , undermine , comprise healthy vascularize tissue determine Investigator Inability perceive 10 gram pressure use SemmesWeinstein 5.07 monofilament periulcer area Ankle Brachial index 0.7 1.2 Actively infected ulcer without purulent discharge , ulcer expose bone associate osteomyelitis . Subjects cellulitis , ischemic gangrenous ulcer opinion Investigator Glycosylated hemoglobin ( HbA1C ) &gt; 12 % Diagnosed and/ currently unstable hypotension , heart block , cardiac failure , cardiac complication Subject diagnosed cancer undergo chemotherapy Revascularization surgery 4 week prior sign ICF Renal failure define serum creatinine &gt; 3.0 mg/dL renal insufficiency require frequent dialysis Poor nutritional status measure serum albumin &lt; 3.0 g/dL Active Charcot structural deformity would prevent adequate offload study foot</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Diabetic foot ulcer</keyword>
	<keyword>Diabetic wound</keyword>
	<keyword>chronic non heal ulcer</keyword>
</DOC>